Literature DB >> 7691863

Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation.

S L Berga1, D S Guzick, S J Winters.   

Abstract

Women with hyperandrogenic anovulation (HAA) have increased circulating levels of LH relative to those of FSH. The cause of this disturbance in gonadotropin secretion is uncertain. Previous investigations have sought to determine if increased GnRH drive is responsible for the excessive LH concentrations. Because previous results have conflicted, we addressed this question by comparing the 24-h secretory patterns of alpha-subunit and LH in women with HAA (n = 9) to those in eumenorrheic women in the midfollicular phase (n = 9). The mean (+/- SEM) pulse frequency was increased in women with HAA compared to that in eumenorrheic women of comparable age and percent ideal body weight for both LH (23.0 +/- 0.7 pulses/24 h vs. 3 17.1 +/- 1.7; P = 0.002) and alpha-subunit (23.0 +/- 0.8 vs. 19.1 +/- 1.2; P = 0.02). LH and alpha-subunit, but not FSH, responses to a submaximal dose of exogenous GnRH were increased in HAA, as were basal LH and alpha-subunit levels (P < 0.01). The present observations provide evidence for increased GnRH drive, including pulse frequency, in HAA. Although the results confirm the presence of a disturbance in gonadotropin secretion and suggest that its proximate cause may be of hypothalamic origin, they do not exclude the possibility that other factors, perhaps of ovarian origin, play a role in the establishment and/or maintenance of the altered gonadotropin secretory patterns and the chronic anovulation characteristic of HAA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691863     DOI: 10.1210/jcem.77.4.7691863

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 2.  Estrogen-progestagen therapy in the management of the polycystic ovary syndrome.

Authors:  J C Marshall
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 3.  Polycystic ovary syndrome in adolescence.

Authors:  Colleen Buggs; Robert L Rosenfield
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

4.  Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS.

Authors:  Rodolfo C Cardoso; Ashleigh Burns; Jacob Moeller; Donal C Skinner; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2016-10-28       Impact factor: 4.736

5.  The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.

Authors:  A D Genazzani; C Battaglia; O Gamba; F Petraglia; B Malavasi; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

6.  Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome.

Authors:  Jennifer F Kawwass; Kristen M Sanders; Tammy L Loucks; Lisa Cencia Rohan; Sarah L Berga
Journal:  Hum Reprod       Date:  2017-07-01       Impact factor: 6.918

7.  Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Susan K Blank; Kristin D Helm; Sandhya Chhabra; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

Review 8.  Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.

Authors:  J E Hall; A E Taylor; F J Hayes; W F Crowley
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 9.  Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

Authors:  M P Leondires; S L Berga
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

Review 10.  Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.

Authors:  Katerina Harwood; Patricia Vuguin; Joan DiMartino-Nardi
Journal:  Horm Res       Date:  2007-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.